NLS Pharmaceutics AG
Stock Forecast, Prediction & Price Target
NLS Pharmaceutics AG Financial Estimates
NLS Pharmaceutics AG Revenue Estimates
NLS Pharmaceutics AG EBITDA Estimates
NLS Pharmaceutics AG Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $132.51M Low: $132.51M High: $132.51M avg. 0% | Avg: $178.62M Low: $178.62M High: $178.62M avg. 34.79% | |
Net Income
% change YoY
| $-11.94M N/A | $-16.49M -38.08% | $-12.17M 26.21% | Avg: $-26.70M Low: $-17.17M High: $-17.17M avg. -119.38% | Avg: $69.54M Low: $43.13M High: $43.13M avg. 360.44% | Avg: $65.66M Low: $65.66M High: $65.66M avg. -5.58% | |
EBITDA
% change YoY
| $-11.85M N/A | $-15.47M -30.55% | $-11.79M 23.75% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$0.81 N/A | -$0.84 -3.70% | -$0.32 61.90% | Avg: -$0.45 Low: -$0.45 High: -$0.45 avg. -40.62% | Avg: $1.13 Low: $1.13 High: $1.13 avg. 351.11% | Avg: $1.72 Low: $1.72 High: $1.72 avg. 52.21% | |
Operating Expenses
% change YoY
| $11.85M N/A | $15.47M 30.55% | $11.80M -23.68% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is NLS Pharmaceutics AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 78.48% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -17.17M, average is -26.70M and high is -17.17M.
What is NLS Pharmaceutics AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 11.59% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is NLS Pharmaceutics AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 120.89% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.45, average is -$0.45 and high is $-0.45.